Cart
sales@molnova.com
Nanterinone
CAS No. 102791-47-9
Nanterinone( —— )
Catalog No. M34663 CAS No. 102791-47-9
Nanterinone (UK 61260), an orally available partial phosphodiesterase inhibitor, is a novel positive inotropic and balanced vasodilator compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 342 | In Stock |
|
| 10MG | 504 | In Stock |
|
| 25MG | 816 | In Stock |
|
| 50MG | 1097 | In Stock |
|
| 100MG | 1479 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2967 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNanterinone
-
NoteResearch use only, not for human use.
-
Brief DescriptionNanterinone (UK 61260), an orally available partial phosphodiesterase inhibitor, is a novel positive inotropic and balanced vasodilator compound.
-
DescriptionNanterinone (UK 61260) is a positive inotropic and arterial vasodilating agent. Nanterinone is a phosphodiesterase inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number102791-47-9
-
Formula Weight253.3
-
Molecular FormulaC15H15N3O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1N(C=C(C)N1)C=2C=C3C(=C(C)C2)NC(=O)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Remme WJ, et al. Acute hemodynamic effects and preload-dependent cardiovascular profile of the partial phosphodiesterase inhibitor nanterinone in patients with mild to moderate heart failure. Cardiovasc Drugs Ther. 1996 May;10(2):137-44.?
molnova catalog
related products
-
Torbafylline
Torbafylline, a xanthine derivative, is a phosphodiesterase (PDE) inhibitor that attenuates burn-induced protein hydrolysis in rat skeletal muscle through activation of the PDE4/cAMP/EPAC/PI3K/Akt pathway.
-
Lodenafil
Lodenafil is a potent PDE5 inhibitor with treatment of erectile dysfunction (ED).
-
Darutigenol
Darutigenol has obvious antithrombotic effect, its mechanism may be related to inhibition of platelet aggregation and adhesion.
